Cargando…

Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes

OBJECTIVE: To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS: We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence...

Descripción completa

Detalles Bibliográficos
Autores principales: Rausch, Joseph R., Hood, Korey K., Delamater, Alan, Shroff Pendley, Jennifer, Rohan, Jennifer M., Reeves, Grafton, Dolan, Lawrence, Drotar, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357213/
https://www.ncbi.nlm.nih.gov/pubmed/22474040
http://dx.doi.org/10.2337/dc11-2163
_version_ 1782233637540855808
author Rausch, Joseph R.
Hood, Korey K.
Delamater, Alan
Shroff Pendley, Jennifer
Rohan, Jennifer M.
Reeves, Grafton
Dolan, Lawrence
Drotar, Dennis
author_facet Rausch, Joseph R.
Hood, Korey K.
Delamater, Alan
Shroff Pendley, Jennifer
Rohan, Jennifer M.
Reeves, Grafton
Dolan, Lawrence
Drotar, Dennis
author_sort Rausch, Joseph R.
collection PubMed
description OBJECTIVE: To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS: We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence (aged 9–11 years) to describe the mutual influences of glycemic control as measured by HbA(1c) and treatment adherence as measured by blood glucose monitoring frequency (BGMF) during the transition to adolescence. RESULTS: HbA(1c) increased from 8.2 to 8.6% (P < 0.001) and BGMF decreased from 4.9 to 4.5 checks per day (P < 0.02) during the 2-year period. Changes in the BGMF slope predicted changes in HbA(1c). A change (increase) in HbA(1c) was associated with a change (decrease) in BGMF of 1.26 (P < 0.001) after controlling for covariates. CONCLUSIONS: The magnitude of the effect of declining treatment adherence (BGMF) on glycemic control in young adolescents may be even greater than declines observed among older adolescents. BGMF offers a powerful tool for targeted management of glycemic control for type 1 diabetes during the critical transition to adolescence.
format Online
Article
Text
id pubmed-3357213
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-33572132013-06-01 Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes Rausch, Joseph R. Hood, Korey K. Delamater, Alan Shroff Pendley, Jennifer Rohan, Jennifer M. Reeves, Grafton Dolan, Lawrence Drotar, Dennis Diabetes Care Original Research OBJECTIVE: To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS: We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence (aged 9–11 years) to describe the mutual influences of glycemic control as measured by HbA(1c) and treatment adherence as measured by blood glucose monitoring frequency (BGMF) during the transition to adolescence. RESULTS: HbA(1c) increased from 8.2 to 8.6% (P < 0.001) and BGMF decreased from 4.9 to 4.5 checks per day (P < 0.02) during the 2-year period. Changes in the BGMF slope predicted changes in HbA(1c). A change (increase) in HbA(1c) was associated with a change (decrease) in BGMF of 1.26 (P < 0.001) after controlling for covariates. CONCLUSIONS: The magnitude of the effect of declining treatment adherence (BGMF) on glycemic control in young adolescents may be even greater than declines observed among older adolescents. BGMF offers a powerful tool for targeted management of glycemic control for type 1 diabetes during the critical transition to adolescence. American Diabetes Association 2012-06 2012-05-11 /pmc/articles/PMC3357213/ /pubmed/22474040 http://dx.doi.org/10.2337/dc11-2163 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Rausch, Joseph R.
Hood, Korey K.
Delamater, Alan
Shroff Pendley, Jennifer
Rohan, Jennifer M.
Reeves, Grafton
Dolan, Lawrence
Drotar, Dennis
Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes
title Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes
title_full Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes
title_fullStr Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes
title_full_unstemmed Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes
title_short Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes
title_sort changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357213/
https://www.ncbi.nlm.nih.gov/pubmed/22474040
http://dx.doi.org/10.2337/dc11-2163
work_keys_str_mv AT rauschjosephr changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes
AT hoodkoreyk changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes
AT delamateralan changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes
AT shroffpendleyjennifer changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes
AT rohanjenniferm changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes
AT reevesgrafton changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes
AT dolanlawrence changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes
AT drotardennis changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes